Key points are not available for this paper at this time.
Upregulation of CCNE1 by palbociclib confers resistance to palbociclib, which can be reverted by INK128
Goto et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: